Report Detail
COVID-19 Impact on Global Rofecoxib Market Insights, Forecast to 2026
- RnM3979290 |
- 01 June, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Rofecoxib market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rofecoxib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Rofecoxib market is segmented into
Oral Suspension.
Tablet-Form
Segment by Application, the Rofecoxib market is segmented into
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Regional and Country-level Analysis
The Rofecoxib market is analysed and market size information is provided by regions (countries).
The key regions covered in the Rofecoxib market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Rofecoxib Market Share Analysis
Rofecoxib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rofecoxib business, the date to enter into the Rofecoxib market, Rofecoxib product introduction, recent developments, etc.
The major vendors covered:
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
...
1 Study Coverage
- 1.1 Rofecoxib Product Introduction
- 1.2 Market Segments
- 1.3 Key Rofecoxib Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Rofecoxib Market Size Growth Rate by Type
- 1.4.2 Oral Suspension.
- 1.4.3 Tablet-Form
- 1.5 Market by Application
- 1.5.1 Global Rofecoxib Market Size Growth Rate by Application
- 1.5.2 Osteoarthritis
- 1.5.3 Rheumatoid Arthritis
- 1.5.4 Juvenile Rheumatoid Arthritis
- 1.5.5 Acute Pain Conditions
- 1.5.6 Migraine
- 1.5.7 Dysmenorrhea
- 1.6 Coronavirus Disease 2019 (Covid-19): Rofecoxib Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Rofecoxib Industry
- 1.6.1.1 Rofecoxib Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Rofecoxib Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Rofecoxib Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Rofecoxib Market Size Estimates and Forecasts
- 2.1.1 Global Rofecoxib Revenue 2015-2026
- 2.1.2 Global Rofecoxib Sales 2015-2026
- 2.2 Rofecoxib Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Rofecoxib Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Rofecoxib Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rofecoxib Competitor Landscape by Players
- 3.1 Rofecoxib Sales by Manufacturers
- 3.1.1 Rofecoxib Sales by Manufacturers (2015-2020)
- 3.1.2 Rofecoxib Sales Market Share by Manufacturers (2015-2020)
- 3.2 Rofecoxib Revenue by Manufacturers
- 3.2.1 Rofecoxib Revenue by Manufacturers (2015-2020)
- 3.2.2 Rofecoxib Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Rofecoxib Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Rofecoxib Revenue in 2019
- 3.2.5 Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Rofecoxib Price by Manufacturers
- 3.4 Rofecoxib Manufacturing Base Distribution, Product Types
- 3.4.1 Rofecoxib Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Rofecoxib Product Type
- 3.4.3 Date of International Manufacturers Enter into Rofecoxib Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Rofecoxib Market Size by Type (2015-2020)
- 4.1.1 Global Rofecoxib Sales by Type (2015-2020)
- 4.1.2 Global Rofecoxib Revenue by Type (2015-2020)
- 4.1.3 Rofecoxib Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Rofecoxib Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Rofecoxib Sales Forecast by Type (2021-2026)
- 4.2.2 Global Rofecoxib Revenue Forecast by Type (2021-2026)
- 4.2.3 Rofecoxib Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Rofecoxib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Rofecoxib Market Size by Application (2015-2020)
- 5.1.1 Global Rofecoxib Sales by Application (2015-2020)
- 5.1.2 Global Rofecoxib Revenue by Application (2015-2020)
- 5.1.3 Rofecoxib Price by Application (2015-2020)
- 5.2 Rofecoxib Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Rofecoxib Sales Forecast by Application (2021-2026)
- 5.2.2 Global Rofecoxib Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Rofecoxib Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Rofecoxib by Country
- 6.1.1 North America Rofecoxib Sales by Country
- 6.1.2 North America Rofecoxib Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Rofecoxib Market Facts & Figures by Type
- 6.3 North America Rofecoxib Market Facts & Figures by Application
7 Europe
- 7.1 Europe Rofecoxib by Country
- 7.1.1 Europe Rofecoxib Sales by Country
- 7.1.2 Europe Rofecoxib Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Rofecoxib Market Facts & Figures by Type
- 7.3 Europe Rofecoxib Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Rofecoxib by Region
- 8.1.1 Asia Pacific Rofecoxib Sales by Region
- 8.1.2 Asia Pacific Rofecoxib Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Rofecoxib Market Facts & Figures by Type
- 8.3 Asia Pacific Rofecoxib Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Rofecoxib by Country
- 9.1.1 Latin America Rofecoxib Sales by Country
- 9.1.2 Latin America Rofecoxib Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Rofecoxib Market Facts & Figures by Type
- 9.3 Central & South America Rofecoxib Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Rofecoxib by Country
- 10.1.1 Middle East and Africa Rofecoxib Sales by Country
- 10.1.2 Middle East and Africa Rofecoxib Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Rofecoxib Market Facts & Figures by Type
- 10.3 Middle East and Africa Rofecoxib Market Facts & Figures by Application
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description, Business Overview and Total Revenue
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Rofecoxib Products Offered
- 11.1.5 Merck Recent Development
- 11.2 Chengdu Meinkai Chemical Co. LTD
- 11.2.1 Chengdu Meinkai Chemical Co. LTD Corporation Information
- 11.2.2 Chengdu Meinkai Chemical Co. LTD Description, Business Overview and Total Revenue
- 11.2.3 Chengdu Meinkai Chemical Co. LTD Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Products Offered
- 11.2.5 Chengdu Meinkai Chemical Co. LTD Recent Development
- 11.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
- 11.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
- 11.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Description, Business Overview and Total Revenue
- 11.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Products Offered
- 11.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
- 11.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
- 11.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
- 11.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description, Business Overview and Total Revenue
- 11.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Products Offered
- 11.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
- 11.5 Pfizer
- 11.5.1 Pfizer Corporation Information
- 11.5.2 Pfizer Description, Business Overview and Total Revenue
- 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer Rofecoxib Products Offered
- 11.5.5 Pfizer Recent Development
- 11.6 Tremeau
- 11.6.1 Tremeau Corporation Information
- 11.6.2 Tremeau Description, Business Overview and Total Revenue
- 11.6.3 Tremeau Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Tremeau Rofecoxib Products Offered
- 11.6.5 Tremeau Recent Development
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description, Business Overview and Total Revenue
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Rofecoxib Products Offered
- 11.1.5 Merck Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Rofecoxib Market Estimates and Projections by Region
- 12.1.1 Global Rofecoxib Sales Forecast by Regions 2021-2026
- 12.1.2 Global Rofecoxib Revenue Forecast by Regions 2021-2026
- 12.2 North America Rofecoxib Market Size Forecast (2021-2026)
- 12.2.1 North America: Rofecoxib Sales Forecast (2021-2026)
- 12.2.2 North America: Rofecoxib Revenue Forecast (2021-2026)
- 12.2.3 North America: Rofecoxib Market Size Forecast by Country (2021-2026)
- 12.3 Europe Rofecoxib Market Size Forecast (2021-2026)
- 12.3.1 Europe: Rofecoxib Sales Forecast (2021-2026)
- 12.3.2 Europe: Rofecoxib Revenue Forecast (2021-2026)
- 12.3.3 Europe: Rofecoxib Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Rofecoxib Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Rofecoxib Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Rofecoxib Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Rofecoxib Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Rofecoxib Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Rofecoxib Sales Forecast (2021-2026)
- 12.5.2 Latin America: Rofecoxib Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Rofecoxib Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Rofecoxib Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Rofecoxib Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Rofecoxib Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Rofecoxib Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Rofecoxib Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Rofecoxib Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Rofecoxib. Industry analysis & Market Report on COVID-19 Impact on Global Rofecoxib is a syndicated market report, published as COVID-19 Impact on Global Rofecoxib Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Rofecoxib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
